Haemopoietic Progenitor Cell (HPC) Framework and Programs

This review considered the future direction of the haemopoietic progenitor cell (HPC) sector. It aims to ensure continued and improved access to therapy for patients with blood or immune disorders, and those receiving chemotherapy or radiation.

National Haemopoietic Progenitor Cell (HPC) Framework

Review of the HPC sector – final report 2018

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
General public

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.